NEULANDLAB NSE filing

Neuland Labs Schedules 42nd AGM for August 4, 2026, via VC/OAVM

The RealCase readLow impact Neutral

Neuland Laboratories Limited will hold its 42nd Annual General Meeting on August 4, 2026, at 10:00 a.m. IST via Video Conference. The Integrated Annual Report for FY 2025-26 is also available.

Why it matters

This is a standard procedural announcement regarding the AGM and annual report dissemination. It does not involve any new financial performance, strategic changes, or events that would significantly impact the company's stock or operations.

The market read

The announcement is a routine corporate communication regarding the scheduling of the Annual General Meeting and the availability of the annual report. It does not contain any new financial information or significant business updates.

Neuland Laboratories Limited has announced the schedule for its 42nd Annual General Meeting (AGM). The meeting is set to take place on Tuesday, August 4, 2026, commencing at 10:00 a.m. IST.

In compliance with current regulations and circulars from the Ministry of Corporate Affairs (MCA) and SEBI, the AGM will be conducted exclusively through Video Conferencing (VC) or Other Audio-Visual Means (OAVM). This format allows participation without the physical presence of shareholders at a common venue.

The company is also making the Notice of the AGM and the Integrated Annual Report for the financial year 2025-26 available to shareholders. Electronic copies are being sent to those with registered email addresses. For shareholders whose email addresses are not registered, the company is providing a weblink and QR code to access these documents. The documents are also available on the company's website, the websites of BSE and NSE, and NSDL's e-voting portal. Shareholders can request a physical copy of the Integrated Annual Report by emailing AGM2026@neulandlabs.com. Those wishing to register their email addresses can contact their Depository Participant or the company's Registrar and Share Transfer Agent.

Filing to action

What to do with a filing like this

Neuland Laboratories Limited filed this with the NSE as a statutory disclosure, categorised under agm. It is a primary document, not a recommendation, and the desk marks it low impact, the band that almost never moves a portfolio on its own.

That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.

See the model portfolios
Primary source

A plain-language summary of a public exchange filing by Neuland Laboratories Limited. Read the original for the full detail.

View original filing